Abstract
Thirteen strains of Chlamydia trachomatis were exposed to subinhibitory concentrations of erythromycin (0.5 microg ml(-1)), azithromycin (0.5 microg ml(-1)) and josamycin (0.04 microg ml(-1)) to select macrolide-resistant mutants with serial passages. The C. trachomatis mutants presented with low-level resistance to erythromycin, azithromycin and josamycin for which a 16-fold increase, a 16-fold increase and an 8-fold increase respectively in the minimal inhibitory concentration (MICs) for the mutant strains compared with the MIC for the susceptible strains were found. The results of chemosensitivity showed that josamycin had the highest susceptibility rate compared with erythromycin and azithromycin in the treatment of C. trachomatis. The ribosomal protein L4 and 23S rRNA genes of the susceptible and resistant strains of C. trachomatis were partially sequenced. A double mutation was found in ribosomal protein L4 of the mutants, leading to Pro109(CCG)-->Leu(CTG), and Pro151(CCG)-->Ala(GCC) (Escherichia coli numbering) in the corresponding protein, but these mutations were also found in parent strains. An investigation into the sequences of 23S rRNAs in the mutants revealed point mutations of A2057G, A2059G and T2611C (E. coli n...Continue Reading
References
Feb 1, 1992·Antimicrobial Agents and Chemotherapy·L E WelshT C Quinn
Nov 1, 1980·Antimicrobial Agents and Chemotherapy·A MouradJ Schachter
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Jan 1, 1994·Infection·M Michéa-HamzehpourJ C Pechère
Oct 3, 1998·Antimicrobial Agents and Chemotherapy·S Dessus-BabusB de Barbeyrac
Nov 14, 1998·Journal of Molecular Biology·P OstergaardR A Garrett
Dec 3, 1999·Antimicrobial Agents and Chemotherapy·M C RobertsH Seppala
Apr 14, 2000·The Journal of Infectious Diseases·J SomaniC M Black
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·B Vester, S Douthwaite
Jun 22, 2001·Journal of Bacteriology·S T GregoryA E Dahlberg
Jul 14, 2001·Antimicrobial Agents and Chemotherapy·J LenartD D Rockey
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·Annie CanuRoland Leclercq
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Marja PihlajamäkiJari Jalava
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·R J SuchlandWalter E Stamm
Jul 3, 2003·Journal of Bacteriology·Rita BerisioAda Yonath
Mar 30, 2004·Antimicrobial Agents and Chemotherapy·O Y MisyurinaV M Govorun
May 28, 2004·The Journal of Antimicrobial Chemotherapy·Priscilla B Wyrick, Stephen T Knight
Jul 9, 2004·Critical Reviews in Microbiology·Daniele Corsaro, Danielle Venditti
Feb 18, 2005·The Journal of Infectious Diseases·Susan A WangKing K Holmes
Feb 25, 2005·Antimicrobial Agents and Chemotherapy·Andrei KutlinPaul Riska
Mar 30, 2005·Proceedings of the National Academy of Sciences of the United States of America·Peter PfisterErik C Böttger
Aug 1, 2006·Sexually Transmitted Infections·P Horner
Oct 3, 2007·Antimicrobial Agents and Chemotherapy·Rachel Binet, Anthony T Maurelli
Citations
Jul 23, 2013·International Journal of Antimicrobial Agents·Cláudia GomesJoaquim Ruiz
Nov 28, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Cláudia GomesJoaquim Ruiz
Aug 21, 2013·BMC Infectious Diseases·Jane S HockingUNKNOWN Australian Chlamydia Treatment Study (ACTS) investigators
Mar 8, 2013·Future Microbiology·Jane S HockingSepehr N Tabrizi
Feb 26, 2015·Pathology·Ella TrembizkiJimmy Twin
Nov 13, 2014·BMC Infectious Diseases·Mette T ChristiansenJudith Breuer
Jul 30, 2015·BMC Infectious Diseases·Fabian Yuh Shiong Kong, Jane Simone Hocking
May 13, 2017·PloS One·Lenka A VodstrcilJane S Hocking
Aug 6, 2020·Pathogens·Andrea KinnearMurray D Jelinski
Sep 25, 2012·Sexually Transmitted Diseases·UNKNOWN A2058G Prevalence Workgroup
Jun 22, 2021·Access Microbiology·Mark ThomasWilhelmina M Huston
Sep 5, 2021·Annals of Clinical Microbiology and Antimicrobials·Ichrak BenamriFouzia Radouani
Mar 26, 2019··Ichrak BenamriFouzia Radouani